Carpenter Technology Corp CRS
We take great care to ensure that the data presented and summarized in this overview for CARPENTER TECHNOLOGY CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CRS
View all-
Black Rock Inc. New York, NY7.63MShares$2.12 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$1.39 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.31MShares$643 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA2.11MShares$587 Million0.08% of portfolio
-
John Armitage Egerton Capital (Uk) LLP1.82MShares$507 Million4.58% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.65MShares$460 Million0.08% of portfolio
-
Surgo Cap Partners LP New York, NY1.61MShares$449 Million14.43% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$363 Million0.02% of portfolio
-
Daniel Loeb Third Point LLC | New York, Ny870KShares$242 Million3.4% of portfolio
-
Advent International Corp Boston, MA805KShares$224 Million4.62% of portfolio
Latest Institutional Activity in CRS
Top Purchases
Top Sells
About CRS
Carpenter Technology Corporation engages in the manufacture, fabrication, and distribution of specialty metals in the United States, Europe, the Asia Pacific, Mexico, Canada, and internationally. It operates in two segments, Specialty Alloys Operations and Performance Engineered Products. The company offers specialty alloys, including titanium alloys, powder metals, stainless steels, alloy steels, and tool steels, as well as additives, and metal powders and parts. It serves aerospace, defense, medical, transportation, energy, industrial, and consumer markets. The company was founded in 1889 and is headquartered in Philadelphia, Pennsylvania.
Insider Transactions at CRS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 15
2025
|
Elizabeth A Socci VP, Contr & Ch Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,752
-11.33%
|
$487,056
$278.55 P/Share
|
|
Jul 15
2025
|
Elizabeth A Socci VP, Contr & Ch Acctg Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,020
+20.64%
|
-
|
|
Jul 15
2025
|
Tony R Thene President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
44,322
-7.44%
|
$12,321,516
$278.55 P/Share
|
|
Jul 15
2025
|
Tony R Thene President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
101,422
+14.55%
|
-
|
|
Jul 15
2025
|
Marshall D Akins VP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,924
-13.7%
|
$1,368,872
$278.55 P/Share
|
|
Jul 15
2025
|
Marshall D Akins VP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,720
+22.98%
|
-
|
|
Jul 15
2025
|
James D Dee SVP, Gen Counsel & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
6,590
-6.79%
|
$1,832,020
$278.55 P/Share
|
|
Jul 15
2025
|
James D Dee SVP, Gen Counsel & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
12,058
+11.05%
|
-
|
|
Jul 15
2025
|
Timothy Lain SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,448
-8.87%
|
$2,904,544
$278.55 P/Share
|
|
Jul 15
2025
|
Timothy Lain SVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,776
+16.2%
|
-
|
|
Jul 15
2025
|
Brian J Malloy SVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,232
-10.83%
|
$2,566,496
$278.55 P/Share
|
|
Jul 15
2025
|
Brian J Malloy SVP and COO |
BUY
Grant, award, or other acquisition
|
Direct |
20,098
+19.08%
|
-
|
|
Jun 12
2025
|
Anastasios John Hart Director |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$243,000
$243.72 P/Share
|
|
Jun 12
2025
|
Anastasios John Hart Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$18,000
$18.26 P/Share
|
|
May 21
2025
|
Colleen Pritchett Director |
SELL
Open market or private sale
|
Direct |
1,200
-100.0%
|
$279,600
$233.24 P/Share
|
|
May 21
2025
|
Colleen Pritchett Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+50.0%
|
$55,200
$46.2 P/Share
|
|
May 19
2025
|
James D Dee SVP, Gen Counsel & Sec |
SELL
Open market or private sale
|
Direct |
5,000
-5.55%
|
$1,175,000
$235.03 P/Share
|
|
May 13
2025
|
Steven E Karol Director |
SELL
Bona fide gift
|
Indirect |
245
-0.11%
|
-
|
|
May 01
2025
|
Elizabeth A Socci VP, Contr & Ch Acctg Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.93%
|
$1,010,000
$202.75 P/Share
|
|
Apr 29
2025
|
I Martin Inglis Director |
SELL
Open market or private sale
|
Direct |
3,433
-33.77%
|
$676,301
$197.66 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 201K shares |
|---|---|
| Exercise of conversion of derivative security | 191K shares |
| Payment of exercise price or tax liability | 210K shares |
|---|---|
| Open market or private sale | 71.1K shares |
| Bona fide gift | 2.58K shares |